Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.

The compliance and trust management platform developer has closed a $210m tranche for the round led by SoftBank Vision Fund 2 at a $5.3bn post-money valuation.

Stripe led a $50m second tranche for the corporate charge card provider's latest round, which valued it at $1.6bn.

The cancer therapeutics developer has filed to float on the Nasdaq Global Market, with Taiho Ventures set to achieve an exit.

Starr Insurance and Liberty Mutual Insurance are among the insurance providers that have backed the Bitcoin custodian services provider in its latest round.

GV returned to reinvest in small molecule drug developer Ventus Therapeutics having backed its $60m series A round almost a year ago.

The Pierre Fabre-backed antibody therapy developer has closed a series A round featuring new and founding investors.

AgFunder is among the investors which have exited the agricultural robotics developer, which has been bought by AppHarvest.